First-Line Treatment for Urethritis
The first-line treatment for urethritis is azithromycin 1g orally in a single dose or doxycycline 100mg orally twice daily for 7 days. 1
Diagnostic Approach
Before initiating treatment, confirm the diagnosis of urethritis with at least one of the following:
- Mucopurulent urethral discharge
- Gram stain of urethral secretions showing ≥2 WBCs per oil immersion field
- First-void urine with ≥10 WBCs per high-power field
- Positive leukocyte esterase test on first-void urine 1
Treatment Algorithm
First-Line Treatment Options:
Azithromycin: 1g orally in a single dose
- Advantages: Single-dose therapy improves compliance
- Particularly effective against Chlamydia trachomatis
Doxycycline: 100mg orally twice daily for 7 days
- Equally effective as azithromycin for clinical cure 2
- Preferred for non-gonococcal urethritis
Pathogen-Specific Considerations:
When gonorrhea is suspected or confirmed:
- Add ceftriaxone 1g IM or IV as a single dose 1
- This combination addresses both gonococcal and non-gonococcal causes
For confirmed pathogens:
- Chlamydia trachomatis: Either azithromycin or doxycycline as above 3, 4
- Mycoplasma genitalium: Azithromycin 500mg on day 1, then 250mg daily for 4 days 1
- Ureaplasma urealyticum: Doxycycline 100mg twice daily for 7 days 1
- Trichomonas vaginalis: Metronidazole 2g orally in a single dose 1
Alternative Regimens
If first-line treatments are contraindicated:
- Erythromycin base 500mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 800mg orally four times daily for 7 days
- Ofloxacin 300mg orally twice daily for 7 days
- Levofloxacin 500mg orally once daily for 7 days 1
Management of Persistent or Recurrent Urethritis
If symptoms persist after initial treatment:
- Confirm objective signs of urethritis before retreatment
- Rule out reinfection or non-compliance
- Consider testing for T. vaginalis and tetracycline-resistant U. urealyticum
- Recommended regimen for persistent urethritis:
- Metronidazole 2g orally in a single dose PLUS
- Azithromycin 1g orally in a single dose (if not used initially) 1
Partner Management
- All sexual partners within the preceding 60 days should be referred for evaluation and treatment
- Partners should receive the same treatment as the index patient
- Patients and partners should abstain from sexual intercourse until:
- 7 days after treatment is initiated
- Symptoms have resolved
- Partners have been adequately treated 5
Follow-Up Recommendations
- No test of cure is needed if symptoms resolve
- Patients should return for evaluation if symptoms persist or recur
- Repeat screening is recommended 3 months after treatment 5
- For M. genitalium infections, test of cure should be collected no earlier than 3 weeks after treatment 6
Special Considerations
- HIV-infected patients should receive the same treatment regimens as HIV-negative patients 1
- Antimicrobial resistance is an increasing concern, particularly with M. genitalium
- Single-dose azithromycin may select for macrolide-resistant M. genitalium strains; consider this when choosing initial therapy 6
The evidence strongly supports either azithromycin or doxycycline as first-line therapy for urethritis, with comparable clinical cure rates of approximately 80% 2. Treatment choice should be guided by local resistance patterns and patient-specific factors such as compliance concerns.